Self Sampling for Rapid Turnaround Testing in the Emergency Department

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

533 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-17

Study Completion Date

2020-06-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Consenting adult female patient felt by the provider to require gonorrhea/chlamydia endocervical testing will be asked to provide an additional self sample specimen. The specimen will be sent to the laboratory using conventional diagnostic test for gonorrhea/chlamydia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Rapid Diagnostic Assay for Gonorrhea and Chlamydia

NCT05564299

Urethritis Cervicitis Sexually Transmitted Infections

COMPLETED NA

Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection

NCT00132457

Chlamydia Infections

COMPLETED NA

Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted Infections

NCT03098394

Sexually Transmitted Infection Gonorrhea Female Chlamydia Females

TERMINATED NA

Emergency Department, Rapid Assessment for Sexually Transmitted Infection

NCT02386514

Infection

COMPLETED

Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing

NCT01849653

Chlamydial Infection Gonococcal Infection

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study protocol:

1. Initial emergency department history and physical examination (standard procedure).

a. Provider identifies patient who is felt to require gonorrhea/chlamydia testing.

i. Provider will contact study staff to consent patient. b. Study staff identifies patient who is felt by provider to require gonorrhea/chlamydia testing. i. Study staff will ask provider if they could move forward with consenting patient.

c. Provider who is study staff identifies patient who is felt to require gonorrhea/chlamydia testing.
2. Study staff will attempt to consent patient.

1. If inclusion criteria are met, and there are no exclusion criteria, written informed consent is obtained.
2. If the patient changes her mind and refuses consent at this point, a notation is written on the front of the research packet, and it is turned in with a refusal notice on the packet.

* If patient refuses to participate in the self-sampling portion of the study, we will ask patients if they would like to fill out the first half of the patient survey that will contain no personal identification information besides their initials.
3. If patient agrees to participate in the self-sampling, the patient is asked to fill out both page one and page two of the survey after consent is obtained.
4. An attempt is made to write down at least two contact telephone numbers for patients who have given informed consent on page 2 of the patient survey.
5. The patient obtains vaginal self-sample in the restroom/exam room.

1. A preprinted single-use instruction sheet is given to patient detailing sample collection.
2. Vaginal self-sampling collection container has preprinted instructions/requisition and a preprinted label on the Cepheid sample tube to the lab denoting this as research sample.
3. Paper requisition form is also included with the sample which helps with documentation and assigning this sample to be billed to the research study and not to the patient.
4. The patient returns the collection container after obtaining the sample to study staff that consented the patient.
5. The collection container will be sent to the lab via pneumatic tube station.
6. Vaginal self-sampling result is documented in Epic with designation showing differentiation from provider-performed endocervical sampling.
6. Provider-performed endocervical sampling is performed once the patient is assigned a provider and given a private area to conduct a provider-performed endocervical sampling (standard procedure).

a. The collection container is sent to the lab, and the final result is noted in the medical record as per standard practice (standard procedure).
7. Retrospective chart review is performed three days after patient consented in order to obtain provider-performed endocervical sampling results.
8. Patient will be contacted only if there is a false-negative. A positive with either the self-sample or provider collected sample is considered positive, and patient will not be called back about that

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chlamydia Trachomatis Neisseria Gonorrhoeae

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vaginal self-sampling and provider performed endocervical sampling

Patients will take part in both provider-performed endocervical sampling (standard care) and vaginal self-sampling.

Group Type EXPERIMENTAL

vaginal self sampling

Intervention Type PROCEDURE

This is a prospective, non-inferiority trial comparing two methods of collection using a US Food and Drug Administration- cleared 90-minute rapid nucleic acid amplification assay, the Xpert CT/NG assay. Any adult female patient admitted to the Emergency Department at Community Regional Medical Center felt by the provider to require gonorrhea/chlamydia endocervical testing may be entered in the study.

provider-performed endocervical sampling

Intervention Type PROCEDURE

provider-performed endocervical sampling is the gold standard for both gonorrhea and chlamydia. The provider takes a endocervical sample which will get sent to the laboratory as the standard care in comparison to the device being studied.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

vaginal self sampling

This is a prospective, non-inferiority trial comparing two methods of collection using a US Food and Drug Administration- cleared 90-minute rapid nucleic acid amplification assay, the Xpert CT/NG assay. Any adult female patient admitted to the Emergency Department at Community Regional Medical Center felt by the provider to require gonorrhea/chlamydia endocervical testing may be entered in the study.

Intervention Type PROCEDURE

provider-performed endocervical sampling

provider-performed endocervical sampling is the gold standard for both gonorrhea and chlamydia. The provider takes a endocervical sample which will get sent to the laboratory as the standard care in comparison to the device being studied.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cepheid, SWAB/A-50

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult female emergency department patient felt by the provider to require gonorrhea/chlamydia endocervical testing

Exclusion Criteria

* Non-English speakers with the exception of Spanish speakers (once a Spanish-language informed consent document is approved by the Community Medical Center Institutional Review Board)
* Prisoner
* Age \<18 years old
* Active psychiatric condition felt to preclude the ability to give informed consent
* Treated for gonorrhea/chlamydia within previous four weeks

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No